HomeFile

File

View Category
Pulmonary Valve

Endovascular Therapy for PE: Earlier Rather than Later Treatment, as in MI and Stroke?

Patients with pulmonary embolism (PE), whether intermediate-high or high risk, may progress to right ventricular (RV) dysfunction,...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

5th Generation Balloon Expandable Valve in a Real World US Population: One-Year Outcomes

Transcatheter aortic valve replacement (TAVR) has consolidated as treatment for severe symptomatic aortic stenosis, even in low...
Dr. Andrés Rodríguez -
Learn More
Mitral valve

Percutaneous Treatment of Atrial Functional Mitral Regurgitation

Atrial functional mitral regurgitation (aFMR), which results from atrial dilation without significant left ventricular dysfunction, accounts for...
Dr. Carlos Fava -
Learn More
Structural heart disease

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

While transcatheter aortic valve replacement (TAVR) provides durable clinical benefits across a wide range of patients, technical...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Courtesy of Dr. Juan Manuel Pérez. Spontaneous left main dissection in an uncommon, and potentially life-threatening, cause of...
Dr. Juan Manuel Pérez -
Learn More
Acute coronary syndromes

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this...
Dr. Omar Tupayachi -
Learn More